本研究旨在通过减少接受新患者的平均时间以及患者接受与首次预约之间的延迟来提高阿曼马斯喀特苏丹卡布斯综合癌症护理和研究中心 (SQCCCRC) 转诊系统的效率。一组前测-后测准实验项目于2022年第2季度至2023年第2季度进行。比较前测和后测阶段收集的数据，以评估干预措施对患者平均接受天数和接受时间的影响。接受后的第一次预约。干预措施包括开发一个全面的转介系统，其中包括技术开发、改进的可及性、定向材料、内部培训、政策制定、标准定义以及针对专业项目定制接受标准。还开展了宣传活动，以教育患者了解转诊流程和可用的交通选择。该项目遵循 FOCUS PDCA（查找、组织、澄清、理解、选择、计划、执行、检查、行动）方法进行实施。肿瘤转诊流程得到显着改善，患者接受平均天数从 4.3 天减少至实施后 1.3 天。统计分析证实了这一变化的显着性（F 值 = 46.25，p < .0001）。同样，在统计支持下，接受后首次就诊预约的平均天数从 8.6 天减少到 4.0 天（F 值 = 6.29，p < .0）。这项研究代表了优化肿瘤转诊流程的重大进步。与之前的研究结果结合起来考虑时，它强调了持续努力提高患者转诊效率的重要性。

This study aimed to enhance the efficiency of the referral system at the Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) in Muscat, Oman by reducing the average time for new patients' acceptance and the delay between patient acceptance and their first appointment.A one-group pretest-posttest quasi-experimental project was conducted from Quarter 2 of 2022 to Quarter 2 of 2023. Data collected during the pretest and posttest phases were compared to evaluate the impact of interventions on the average days for patient acceptance and the time to first appointment after acceptance. The intervention involved developing a comprehensive referral system incorporating technology development, improved accessibility, orientation materials, internal training, policy formulation, criteria definition, and tailoring acceptance criteria to specialty programs. Awareness campaigns were also conducted to educate patients about the referral process and available transportation options. The project followed the FOCUS PDCA (Find, Organize, Clarify, Understand, Select, Plan, Do, Check, Act) approach for implementation.Significant improvements were observed in the oncology referral process, with the average days for patient acceptance decreasing from 4.3 days to 1.3 days post-implementation. Statistical analysis confirmed the significance of this change (F-value = 46.25, p < .0001). Similarly, the average days to first visit appointment after acceptance decreased from 8.6 days to 4.0 days, with statistical support (F-value = 6.29, p < .0).This study represents a significant advancement in optimizing the oncology referral process. When considered in conjunction with previous research findings, it underscores the importance of ongoing efforts to enhance efficiency in patient referrals.